Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05766982Not ApplicableWithdrawn

Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)

Role: lead

NCT03535766Completed

An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

Role: lead

NCT03560791Completed

A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence

Role: lead

NCT04327830Unknown

What Older Adults and Their Caregivers Need for Making Better Decisions at Home

Role: collaborator

NCT03001765Not ApplicableCompleted

Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia

Role: lead

NCT02924207Not ApplicableCompleted

Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes

Role: lead

All 6 trials loaded